Stockreport

Tiziana Life Sciences Files Patent on Combination of Nanoparticle-Actinomycin D with Anti-Interleukin-6 Receptor Monoclonal Antibody for Treatment of Coronaviruses

Tiziana Life Sciences Ltd - Common Shares  (TLSA) 
PDF This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. NEW YORK and LONDON, April 27, 2020 (GLOBE NEWSWIRE) -- Tiziana [Read more]